Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ALKS
CYTK
Add up to 3 more stocks
ALKS
Alkermes plc
-3.12%
$41.42-1.34Delayed quote: Oct 6, 2026, 10:20 AM EDT
Market Cap
$6.95B
52W Range
$27.00 - $55.67
CYTK
Cytokinetics, Incorporated
-2.65%
$61.04-1.66Delayed quote: Oct 6, 2026, 10:20 AM EDT
Market Cap
$7.60B
52W Range
$54.30 - $88.31
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 108.16 | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 3.84 | N/A |
| P/S Ratio | 4.17 | 107.04 |
| P/FCF Ratio | 31.36 | N/A |
| EV/EBITDA | 44.77 | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 84.6% | 85.0% |
| Operating Margin | 17.2% | -695.4% |
| Net Margin | 4.0% | -1259.9% |
| ROE | 3.7% | N/A |
| ROA | 1.5% | -46.5% |
| ROIC | 2.1% | -39.8% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 2.30 | 6.66 |
| Quick Ratio | 1.85 | 6.66 |
| Debt/Equity | 0.87 | N/A |
| Interest Coverage | 20.69 | -5.89 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.